aysun erdem yaman

Dr. aysun erdem yaman

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
SYSelçuk Yazıcı
Selçuk Yazıcı
TKTuncay Kırış
Tuncay Kırış
AEAyşe Emre
Ayşe Emre
UCUfuk S. Ceylan
Ufuk S. Ceylan
ŞAŞükrü Akyüz
Şükrü Akyüz
KYKemal Yeşilçimen
Kemal Yeşilçimen

9 January 2022 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
DKDeniz Kirac
Deniz Kirac
AYaysun erdem yaman
aysun erdem yaman
TDTansu Doran
Tansu Doran
MMMujgan Mihmanli
Mujgan Mihmanli
EKElif Cigdem Keles
Elif Cigdem Keles

29 October 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AYaysun erdem yaman
aysun erdem yaman
UCUfuk Sadık Ceylan
Ufuk Sadık Ceylan
Although some clinical studies have claimed that low-dose vitamin D (Vit-D) increases the risk of long-term cardiac events, in others, no association was found. To better understand the impact of Vit-D levels on long-term cardiac events in coronary artery disease patients, this study was designed. There were 408 patients with coronary artery disease (CAD). The patients were separated into three groups based on their Vit-D levels: group 1 had levels below 10 ng/mL, group 2 had levels between 10 and 20, and group 3 had levels above 20 ng/mL. Six years were spent monitoring the patients for non-fatal MI, death, vascular revascularization, and stable course data. Mortality was found to be similar between groups (group 1: 24.5%; group 2: 13.8%; group 3: 17.4%; p > 0.05). In group 3, 47.8% of the patients did not experience any cardiac event, while 28.7% in group 2 and 27.6% in group 1 did not experience any cardiac event, and these values were found to be significant in favor of group 3 (p = 0.006). Group 3 was found to have considerably lower rates of non-ST-elevated myocardial infarction (non-STEMI) and unstable angina (UA) than the other groups did (group 1: 49%; group 2: 38%; group 3: 27%; p = 0.001). In conclusion, although vitamin D deficiency does not accompany an increase in mortality, it is associated with an increase in non-STEMI and UA in patients who have previously been diagnosed with CAD.

1 January 2024 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
AYaysun erdem yaman
aysun erdem yaman
Background: Intraluminal thrombi in the abdominal aortic aneurysms (AAA) were dem- onstrated to increase aneurysm growth. The effect of treatments on thrombus reduction upon AAA enlargement and clinical endpoints is uncertain Therefore, this study aimed to investigate the effect of antiplatelet and anticoagulant therapy on AAA growth and clinical outcomes. Method: A total of 357 patients with AAAs were enrolled in this study. They were divided into 2 groups based on their medical therapies. Patients on antiplatelet and anticoagu- lant therapy were assigned to group 1 (n = 234) and group 2 (n = 92), respectively. Results: The greatest reduction in thrombus diameter change was observed in patients with anticoagulant therapy (group 1, -2.26 mm; group 2, -8.16 mm; P = .001). The greatest aneurysmal enlargement was found in patients with antiplatelet therapy. There was less AAA progression with anticoagulant therapy than with the other therapy (group 1, 2.08 mm; group 2, 1.31 mm P = .027. The more operational need was observed in patients with antiplatelet therapy than in patients with anticoagulant therapy (group 1 67, group 2 16, P = .036) Conclusion: In our study, it was revealed that anticoagulant therapy has been associated with decreased thrombus diameter and less aneurysmal enlargement compared with antiplatelet therapy. Furthermore, this beneficial effect on the thrombus size and aneu- rysmal diameter decreased the operational need in patients with anticoagulant therapy.

1 September 2016 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
AYaysun erdem yaman
aysun erdem yaman
UCUfuk Sadik Ceylan
Ufuk Sadik Ceylan
AEAycan Esen
Aycan Esen
EZErtugrul Zencirci
Ertugrul Zencirci
BTBirol Topcu
Birol Topcu
KYKemal Yesilcimen
Kemal Yesilcimen
Clinical usefulness of red cell distribution width to angiographic severity and coronary stent thrombosis Aysun Erdem,1 Ufuk Sadik Ceylan,1 Aycan Esen,1 Ertugrul Zencirci,2 Birol Topcu,3 Kivilcim Ozden,1 Selcuk Yazici,1 Sait Terzi,1 Ayse Emre,1 Kemal Yesilcimen1 1Department of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey; 2Department of Cardiology, Acibadem Hospital Maslak, Istanbul, Turkey; 3Department of Biostatistics, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey Background: Red cell distribution width (RDW) is a quantitative measurement and shows heterogeneity of red blood cell size in peripheral blood. RDW has recently been associated with cardiovascular events and cardiovascular diseases, and it is a novel predictor of mortality. In this study, we aimed to evaluate the clinical usefulness of measuring RDW in patients with coronary stent thrombosis.Patients and methods: We retrospectively reviewed 3,925 consecutive patients who presented with acute coronary syndrome and who underwent coronary angiography at the Siyami Ersek Hospital between May 2011 and December 2013. Of the 3,925 patients, 73 patients (55 males, mean age 59±11 years, 55 with ST elevated myocardial infarction) with stent thrombosis formed group 1. Another 54 consecutive patients who presented with acute coronary syndrome (without coronary stent thrombosis, 22 patients with ST elevated myocardial infarction, 44 males, mean age 54±2 years) and underwent percutaneous coronary intervention in May 2011 formed group 2. Data were collected from all groups for 2 years. The RDW values were calculated from patients 1 month later at follow-up. Syntax scores were calculated for all the patients. The patients were also divided as low syntax score group and moderate–high syntax score group.Results: The patients in group 1 with stent thrombosis had significantly higher RDW level (13.85) than the patients in group 2 without stent thrombosis (12) (P

6 November 2019 in World Journal of Clinical Cases
Verified
Journal Article
Open access
AYaysun erdem yaman
aysun erdem yaman
AZAycan Esen Zencirci
Aycan Esen Zencirci
KOKivilcim Ozden
Kivilcim Ozden
STSait Terzi
Sait Terzi
Transcatheter aortic valve replacement (TAVR) is recommended in patients with severe aortic stenosis who have high surgical risk. However, in the pre-existing mechanical mitral valve prosthesis and natural pure aortic regurgitation, TAVR is relatively contraindicated. In this report, we described one case of TAVR with native aortic regurgitation in the presence of mechanical mitral valve prosthesis. A 64-year-old man with a medical history of mitral valve replacement had severe dyspnea and was symptomatic even at rest for 3 mo. His echocardiography showed severe native pure aortic regurgitation. His euroscore was 15. A TAVR procedure with an evolut R was planned. A 34 mm evolut R was placed by transesophageal echocardiography. The mitral prosthesis was functioning normally, and mild-moderate paravalvular leakage was evident by transesophageal echocardiography. The patient recovered without any complication. At 1 mo follow up, the patient was well, and no paravalvular leakage was noted. TAVR for pure aortic regurgitation in the presence of prosthetic mitral valve can be a safe procedure.